Tariff pause eases pressure on drug companies

Tariff pause eases pressure on drug companies

Mumbai: The White House’s reported decision to shelve plans for tariff on generic drug imports will be a relief to Indian pharmaceutical companies, which account for nearly half of all generic prescriptions in the United States. Industry experts said even as there was a lot of speculation about tariff imposition across the pharma community, promoters…

Read More